查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2146834

生物可吸收Sirolimus洗脫冠狀動脈支架系統市場：全球市場預測，2026-2032年

Bioabsorbable Sirolimus-eluting Coronary Stent System Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物可吸收Sirolimus洗脫冠狀動脈支架系統的市場規模將達到 32.2 億美元，複合年成長率為 12.62%。

主要市場統計數據
基準年 2025 14億美元
預計年份：2026年 15.7億美元
預測年份 2032 32.2億美元
複合年成長率 (%) 12.62%

生物可吸收Sirolimus洗脫冠狀動脈支架系統：概述

生物可吸收的Sirolimus洗脫冠狀動脈支架系統旨在透過釋放Sirolimus來抑制新生內膜增生，同時提供暫時的血管支撐，其長期目標是減輕與永久性金屬支架相關的長期植入負擔。其臨床意義取決於以下幾個方面的平衡：徑向支撐、藥物控釋、支架厚度的影響、植入的便利性、內皮功能的恢復，以及證明其在患者群體中安全性和有效性所需的證據。

臨床證據和設備設計正在改變我們應用這些技術的方式。

隨著對支架吸收、血栓症風險、機械完整性、植入技術和長期臨床療效的深入研究，該領域的模式正在改變。目前，研發工作越來越注重更薄的結構、更可預測的分解、更高的滲透性、更強的病灶穿透性能以及與血管內成像的兼容性。治療指南的修訂、上市後監測、操作者訓練、保險報銷條件以及持久性藥物釋放型支架的出現，也正在影響支架的應用趨勢。

人工智慧可以增強開發、規劃和後續工作。

人工智慧可以透過改善病灶評估、影像診斷、患者篩選、手術規劃和長期後續觀察支持這一領域。機器學習工具可以幫助識別與植入挑戰和不良後果相關的解剖特徵，而影像分析可以輔助確定植入物尺寸、評估擴張狀態以及檢測擴張不足或植入位置不當。這些應用仍然依賴具有代表性的資料集、臨床檢驗、透明的性能標準、網路安全以及與臨床醫生主導的決策過程的精心整合。

區域差異反映了法規、基礎設施和臨床實踐。

在北美，重點通常放在嚴謹的臨床證據、監管文件、衛生經濟學論點和先進的介入治療基礎設施。在歐洲，集中化的監管要求與各國特定的報銷方案和醫院採購考量相結合。在亞太地區，雖然手術能力很強，但可及性各不相同，且推廣途徑也多種多樣。拉丁美洲受到進口要求、公立和私立醫療保健差異以及專科醫生集中程度的影響。在中東，先進的三級醫療機構通常與集中採購系統相結合，而在非洲，導管檢查室的容量、成本效益和追蹤連續性方面存在更大的差異。

經濟和政治集團影響准入和證據要求。

在東協市場，必須了解各會員國不同的監管管道、採購體系和專家資源。金磚國家擁有龐大且多元化的醫療保健體系，因此本地證據、生產能力和經濟實力是重要的考量。在歐盟，除了通用的監管流程外，各國的報銷政策也會影響醫療產品的實施。七國集團（G7）的醫療保健體系通常強調比較臨床證據、安全監測和價值評估。海灣合作理事會（GCC）國家的醫療保健體系通常以集中採購體系和先進的都市區醫院為特徵，而北約成員國雖然可能受益於成熟的醫療設備基礎設施，但在報銷機制和監管實踐方面仍然存在顯著差異。

成熟和發展中的醫療保健系統因國家而異，其優先事項也各不相同。

澳洲和加拿大由於其醫療保健系統地域分散，強調循證報銷和專家主導的醫療服務。巴西、墨西哥、印度、俄羅斯和南非則需要仔細考慮監管、採購、定價和區域准入的差異。中國擁有強大的介入治療能力，同時監管和採購要求也在不斷發展。日本高度重視臨床評估、手術品質和遵守當地法規。韓國擁有先進的醫院基礎設施和技術評估體系。法國、德國、義大利、西班牙和英國雖然通用歐洲，但在報銷結構、醫院採購、指南解讀和證據要求方面存在差異。美國尤其重視監管證據、上市後監測、編碼、保險覆蓋範圍和手術經濟性。

優先考慮證據、技術和醫療系統的準備。

行業領導者應優先進行設計完善的對比研究，並進行有意義的長期隨訪，透明地報告支架相關事件，以及針對複雜病變和高風險患者的亞組分析。產品開發應著重於機械可靠性、可控吸收、遞送、影像相容性和便捷的植入方式。上市準備工作應包括系統的操作人員培訓、基於影像的植入方案、上市後註冊登記、衛生經濟學分析以及針對不同國家的報銷策略。與醫院和臨床協會建立合作關係將有助於確定合適的應用途徑，避免過度誇大超出證據範圍的益處。

整合證據需要結合臨床實務、監管架構和市場進入方面的資訊來源。

嚴謹的調查方法應整契約儕審查的臨床研究、隨機對照試驗和觀察性研究的證據，以及監管文件、專家指南、醫療技術評估、報銷政策、採購資訊和上市後安全性資訊。研究結果應跨地區和跨醫療機構進行全面審查，並明確檢驗研究設計、追蹤期、終點定義、患者選擇、植入方案和報告限制。定性解釋應區分已確立的證據和新興徵兆，並且在缺乏直接比較數據的情況下，應避免推斷臨床意義。

長期檢驗將決定這項技術的作用。

生物可吸收Sirolimus洗脫冠狀動脈支架系統提供了一個具有重要臨床意義的概念：無需永久性支架即可提供臨時支撐和藥物傳輸。其應用取決於安全性、機械性能、吸收特性和患者獲益方面的充分證據，並輔以適當的留置技術和可靠的追蹤研究。要取得進展，最有可能的途徑是讓研發人員、監管機構、臨床醫生、保險公司和醫院在透明的證據標準和精心定義的病患選擇標準方面達成共識。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：生物可吸收Sirolimus洗脫冠狀動脈支架系統市場：依產品類型分類

  • 球囊擴張型
    • 中型支柱
    • 厚壁支柱
    • 薄壁支柱
  • 自膨脹
    • 中型支柱
    • 厚壁支柱
    • 薄壁支柱

第8章：生物可吸收Sirolimus洗脫冠狀動脈支架系統市場：依適應症分類

  • 慢性完全閉塞
  • 心肌梗塞
    • NSTEMI
    • STEMI
  • 穩定性心絞痛
    • 分支
    • 大血管
    • 多血管疾病
    • 單一血管
    • 小血管
  • 不穩定型心絞痛

第9章：生物可吸收Sirolimus洗脫冠狀動脈支架系統市場：依最終用戶分類

  • 門診手術中心
    • 醫院所有
    • 獨立的
  • 醫院
    • 私立醫院
    • 公立醫院
  • 循環系統專科診所

第10章：生物可吸收Sirolimus洗脫冠狀動脈支架系統市場：依通路分類

  • 直接競標
  • 零售藥房
    • 離線頻道
      • 零售
      • 批發的
    • 線上管道
  • 批發分銷

第11章：生物可吸收Sirolimus洗脫冠狀動脈支架系統市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：生物可吸收Sirolimus洗脫冠狀動脈支架系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：生物可吸收Sirolimus洗脫冠狀動脈支架系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Amaranth Medical, Inc.
  • Balton Sp. z oo
  • BIOTRONIK SE & Co. KG
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd.
  • OrbusNeich Medical Group
  • Relisys Medical Devices Limited
  • REVA Medical, Inc.
  • Sino Medical Sciences Technology
  • Svelte Medical Systems, Inc.
  • Translumina GmbH

第16章 主要專家

Product Code: MRR-3D150775E42C

The Bioabsorbable Sirolimus-eluting Coronary Stent System Market is projected to grow by USD 3.22 billion at a CAGR of 12.62% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.40 billion
Estimated Year [2026] USD 1.57 billion
Forecast Year [2032] USD 3.22 billion
CAGR (%) 12.62%

Bioabsorbable Sirolimus-Eluting Coronary Stent Systems: Executive Overview

Bioabsorbable sirolimus-eluting coronary stent systems are designed to provide temporary vessel support while delivering sirolimus to limit neointimal tissue growth, with the longer-term objective of reducing the persistent implant burden associated with permanent metallic platforms. Their clinical relevance depends on balancing radial support, controlled drug release, strut-thickness effects, deliverability, endothelial recovery, and the evidence required to demonstrate safety and effectiveness across patient populations.

Clinical Evidence and Device Design Are Reshaping Adoption

The landscape is being transformed by closer scrutiny of scaffold resorption, thrombosis risk, mechanical integrity, implantation technique, and long-term clinical outcomes. Contemporary development increasingly emphasizes thinner structures, more predictable degradation, improved radiographic visibility, lesion-crossing performance, and compatibility with intravascular imaging. Adoption is also shaped by updated treatment guidelines, post-market surveillance, operator training, reimbursement conditions, and the availability of durable drug-eluting alternatives.

Artificial Intelligence Strengthens Development, Planning, and Follow-Up

Artificial intelligence can support this field by improving lesion assessment, imaging interpretation, patient selection, procedural planning, and longitudinal follow-up. Machine-learning tools may help identify anatomical features associated with deployment challenges or adverse outcomes, while image analysis can assist with sizing, expansion assessment, and detection of underexpansion or malapposition. These applications remain dependent on representative datasets, clinical validation, transparent performance standards, cybersecurity, and careful integration into clinician-led decision-making.

Regional Differences Reflect Regulation, Infrastructure, and Clinical Practice

North America generally emphasizes rigorous clinical evidence, regulatory documentation, health-economic justification, and advanced interventional infrastructure. Europe combines centralized regulatory expectations with country-level reimbursement and hospital procurement considerations. Asia-Pacific contains substantial procedural capability alongside uneven access, creating varied pathways for adoption. Latin America is influenced by import requirements, public-private healthcare differences, and specialist concentration. The Middle East often combines advanced tertiary centers with centralized purchasing, while Africa faces wider variation in catheterization-laboratory capacity, affordability, and follow-up continuity.

Economic and Political Groupings Shape Access and Evidence Requirements

ASEAN markets require attention to differing regulatory pathways, procurement systems, and specialist availability across member states. BRICS countries span large and diverse healthcare systems, making local evidence, manufacturing capability, and affordability important considerations. European Union adoption is affected by shared regulatory processes alongside national reimbursement decisions. G7 systems typically place strong weight on comparative clinical evidence, safety monitoring, and value assessment. GCC healthcare systems often feature centralized procurement and sophisticated urban hospitals, while NATO members may benefit from established medical-device infrastructure but still differ materially in reimbursement and regulatory practice.

Country-Level Priorities Differ Across Mature and Developing Systems

Australia and Canada emphasize evidence-based reimbursement and specialist-led care within geographically dispersed systems. Brazil, Mexico, India, Russia, and South Africa require careful navigation of regulatory, procurement, affordability, and regional-access differences. China combines substantial interventional capacity with evolving regulatory and procurement requirements. Japan places strong importance on clinical evaluation, procedural quality, and local regulatory alignment. South Korea has advanced hospital infrastructure and technology assessment considerations. France, Germany, Italy, Spain, and the United Kingdom differ in reimbursement structures, hospital purchasing, guideline interpretation, and evidence expectations despite their shared European context. The United States places particular emphasis on regulatory evidence, post-market monitoring, coding, coverage, and procedural economics.

Prioritize Evidence, Technique, and Health-System Readiness

Industry leaders should prioritize well-designed comparative studies with meaningful long-term follow-up, transparent reporting of scaffold-related events, and subgroup analysis for complex lesions and high-risk patients. Product development should focus on mechanical reliability, controlled resorption, deliverability, imaging compatibility, and intuitive deployment. Commercial readiness should include structured operator education, imaging-supported implantation protocols, post-market registries, health-economic analyses, and country-specific reimbursement strategies. Partnerships with hospitals and clinical societies can help establish appropriate-use pathways without overstating benefits beyond the evidence.

Evidence Synthesis Should Combine Clinical, Regulatory, and Market-Access Sources

A robust research methodology combines peer-reviewed clinical studies, randomized and observational evidence, regulatory documents, professional guidelines, health-technology assessments, reimbursement policies, procurement information, and post-market safety communications. Findings should be triangulated across regions and healthcare groups, with explicit assessment of study design, follow-up duration, endpoint definitions, patient selection, implantation protocols, and reporting limitations. Qualitative interpretation should distinguish established evidence from emerging signals and should avoid inferring clinical superiority where direct comparative data are insufficient.

Long-Term Validation Will Determine the Technology's Role

Bioabsorbable sirolimus-eluting coronary stent systems offer a clinically meaningful concept: temporary support and drug delivery without a permanent scaffold. Their role will depend on durable evidence of safety, mechanical performance, resorption behavior, and patient benefit, supported by appropriate implantation technique and reliable follow-up. Progress is most likely where developers, regulators, clinicians, payers, and hospitals align around transparent evidence standards and carefully defined patient selection.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Bioabsorbable Sirolimus-eluting Coronary Stent System Market, by Product Type

  • 7.1. Introduction
  • 7.2. Balloon Expandable
    • 7.2.1. Medium Strut
    • 7.2.2. Thick Strut
    • 7.2.3. Thin Strut
  • 7.3. Self Expanding
    • 7.3.1. Medium Strut
    • 7.3.2. Thick Strut
    • 7.3.3. Thin Strut

8. Bioabsorbable Sirolimus-eluting Coronary Stent System Market, by Indication

  • 8.1. Introduction
  • 8.2. Chronic Total Occlusion
  • 8.3. Myocardial Infarction
    • 8.3.1. NSTEMI
    • 8.3.2. STEMI
  • 8.4. Stable Angina
    • 8.4.1. Bifurcation
    • 8.4.2. Large Vessel
    • 8.4.3. Multi Vessel
    • 8.4.4. Single Vessel
    • 8.4.5. Small Vessel
  • 8.5. Unstable Angina

9. Bioabsorbable Sirolimus-eluting Coronary Stent System Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Center
    • 9.2.1. Hospital Owned
    • 9.2.2. Independent
  • 9.3. Hospital
    • 9.3.1. Private Hospital
    • 9.3.2. Public Hospital
  • 9.4. Specialty Cardiology Clinic

10. Bioabsorbable Sirolimus-eluting Coronary Stent System Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Direct Tendering
  • 10.3. Retail Pharmacy
    • 10.3.1. Offline Channel
      • 10.3.1.1. Retail
      • 10.3.1.2. Wholesale
    • 10.3.2. Online Channel
  • 10.4. Wholesale Distribution

11. Bioabsorbable Sirolimus-eluting Coronary Stent System Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. Bioabsorbable Sirolimus-eluting Coronary Stent System Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. Bioabsorbable Sirolimus-eluting Coronary Stent System Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Amaranth Medical, Inc.
  • 15.2. Balton Sp. z o.o.
  • 15.3. BIOTRONIK SE & Co. KG
  • 15.4. Elixir Medical Corporation
  • 15.5. Kyoto Medical Planning Co., Ltd.
  • 15.6. OrbusNeich Medical Group
  • 15.7. Relisys Medical Devices Limited
  • 15.8. REVA Medical, Inc.
  • 15.9. Sino Medical Sciences Technology
  • 15.10. Svelte Medical Systems, Inc.
  • 15.11. Translumina GmbH

16. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market, Years Considered for the Study
  • FIGURE 2. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market, Research Design
  • FIGURE 3. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market, Research Framework
  • FIGURE 4. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market, Data Triangulation
  • FIGURE 5. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2025 vs 2032 (%)
  • FIGURE 9. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 11. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 13. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Segmentation & Coverage
  • TABLE 2. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Balloon Expandable Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Balloon Expandable Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Balloon Expandable Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Medium Strut Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Medium Strut Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Medium Strut Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Thick Strut Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Thick Strut Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Thick Strut Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Thin Strut Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Thin Strut Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Thin Strut Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Self Expanding Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Self Expanding Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Self Expanding Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Medium Strut Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Medium Strut Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Medium Strut Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Thick Strut Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Thick Strut Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Thick Strut Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Thin Strut Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Thin Strut Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Thin Strut Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 29. Global Chronic Total Occlusion Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Chronic Total Occlusion Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Chronic Total Occlusion Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Myocardial Infarction Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global Myocardial Infarction Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global Myocardial Infarction Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global NSTEMI Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global NSTEMI Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global NSTEMI Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global STEMI Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 39. Global STEMI Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 40. Global STEMI Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 41. Global Stable Angina Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global Stable Angina Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global Stable Angina Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global Bifurcation Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Global Bifurcation Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 46. Global Bifurcation Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 47. Global Large Vessel Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 48. Global Large Vessel Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 49. Global Large Vessel Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 50. Global Multi Vessel Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 51. Global Multi Vessel Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 52. Global Multi Vessel Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 53. Global Single Vessel Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 54. Global Single Vessel Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 55. Global Single Vessel Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 56. Global Small Vessel Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Global Small Vessel Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 58. Global Small Vessel Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 59. Global Unstable Angina Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Global Unstable Angina Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 61. Global Unstable Angina Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 62. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 63. Global Ambulatory Surgical Center Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 64. Global Ambulatory Surgical Center Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 65. Global Ambulatory Surgical Center Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 66. Global Hospital Owned Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 67. Global Hospital Owned Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 68. Global Hospital Owned Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 69. Global Independent Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. Global Independent Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 71. Global Independent Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 72. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 73. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 74. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 75. Global Private Hospital Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 76. Global Private Hospital Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 77. Global Private Hospital Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 78. Global Public Hospital Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 79. Global Public Hospital Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 80. Global Public Hospital Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 81. Global Specialty Cardiology Clinic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 82. Global Specialty Cardiology Clinic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 83. Global Specialty Cardiology Clinic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 84. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 85. Global Direct Tendering Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 86. Global Direct Tendering Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 87. Global Direct Tendering Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 88. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 89. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 90. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 91. Global Offline Channel Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 92. Global Offline Channel Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 93. Global Offline Channel Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 94. Global Retail Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 95. Global Retail Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 96. Global Retail Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 97. Global Wholesale Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 98. Global Wholesale Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 99. Global Wholesale Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 100. Global Online Channel Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 101. Global Online Channel Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 102. Global Online Channel Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 103. Global Wholesale Distribution Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 104. Global Wholesale Distribution Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 105. Global Wholesale Distribution Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 106. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 107. Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 108. Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 109. Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Balloon Expandable, 2017-2032 (USD Million)
  • TABLE 110. Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Self Expanding, 2017-2032 (USD Million)
  • TABLE 111. Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 112. Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Myocardial Infarction, 2017-2032 (USD Million)
  • TABLE 113. Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Stable Angina, 2017-2032 (USD Million)
  • TABLE 114. Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 115. Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Ambulatory Surgical Center, 2017-2032 (USD Million)
  • TABLE 116. Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Hospital, 2017-2032 (USD Million)
  • TABLE 117. Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 118. Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 119. Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Offline Channel, 2017-2032 (USD Million)
  • TABLE 120. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 121. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 122. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Balloon Expandable, 2017-2032 (USD Million)
  • TABLE 123. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Self Expanding, 2017-2032 (USD Million)
  • TABLE 124. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 125. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Myocardial Infarction, 2017-2032 (USD Million)
  • TABLE 126. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Stable Angina, 2017-2032 (USD Million)
  • TABLE 127. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 128. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Ambulatory Surgical Center, 2017-2032 (USD Million)
  • TABLE 129. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Hospital, 2017-2032 (USD Million)
  • TABLE 130. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 131. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 132. North America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Offline Channel, 2017-2032 (USD Million)
  • TABLE 133. Latin America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 134. Latin America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 135. Latin America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Balloon Expandable, 2017-2032 (USD Million)
  • TABLE 136. Latin America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Self Expanding, 2017-2032 (USD Million)
  • TABLE 137. Latin America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 138. Latin America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Myocardial Infarction, 2017-2032 (USD Million)
  • TABLE 139. Latin America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Stable Angina, 2017-2032 (USD Million)
  • TABLE 140. Latin America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 141. Latin America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Ambulatory Surgical Center, 2017-2032 (USD Million)
  • TABLE 142. Latin America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Hospital, 2017-2032 (USD Million)
  • TABLE 143. Latin America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 144. Latin America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 145. Latin America Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Offline Channel, 2017-2032 (USD Million)
  • TABLE 146. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 147. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 148. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Balloon Expandable, 2017-2032 (USD Million)
  • TABLE 149. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Self Expanding, 2017-2032 (USD Million)
  • TABLE 150. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 151. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Myocardial Infarction, 2017-2032 (USD Million)
  • TABLE 152. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Stable Angina, 2017-2032 (USD Million)
  • TABLE 153. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 154. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Ambulatory Surgical Center, 2017-2032 (USD Million)
  • TABLE 155. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Hospital, 2017-2032 (USD Million)
  • TABLE 156. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 157. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 158. Europe Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Offline Channel, 2017-2032 (USD Million)
  • TABLE 159. Middle East Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 160. Middle East Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 161. Middle East Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Balloon Expandable, 2017-2032 (USD Million)
  • TABLE 162. Middle East Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Self Expanding, 2017-2032 (USD Million)
  • TABLE 163. Middle East Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 164. Middle East Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Myocardial Infarction, 2017-2032 (USD Million)
  • TABLE 165. Middle East Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Stable Angina, 2017-2032 (USD Million)
  • TABLE 166. Middle East Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 167. Middle East Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Ambulatory Surgical Center, 2017-2032 (USD Million)
  • TABLE 168. Middle East Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Hospital, 2017-2032 (USD Million)
  • TABLE 169. Middle East Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 170. Middle East Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 171. Middle East Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Offline Channel, 2017-2032 (USD Million)
  • TABLE 172. Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 173. Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 174. Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Balloon Expandable, 2017-2032 (USD Million)
  • TABLE 175. Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Self Expanding, 2017-2032 (USD Million)
  • TABLE 176. Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 177. Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Myocardial Infarction, 2017-2032 (USD Million)
  • TABLE 178. Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Stable Angina, 2017-2032 (USD Million)
  • TABLE 179. Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 180. Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Ambulatory Surgical Center, 2017-2032 (USD Million)
  • TABLE 181. Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Hospital, 2017-2032 (USD Million)
  • TABLE 182. Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 183. Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 184. Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Offline Channel, 2017-2032 (USD Million)
  • TABLE 185. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 186. ASEAN Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 187. ASEAN Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 188. ASEAN Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Balloon Expandable, 2017-2032 (USD Million)
  • TABLE 189. ASEAN Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Self Expanding, 2017-2032 (USD Million)
  • TABLE 190. ASEAN Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 191. ASEAN Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Myocardial Infarction, 2017-2032 (USD Million)
  • TABLE 192. ASEAN Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Stable Angina, 2017-2032 (USD Million)
  • TABLE 193. ASEAN Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 194. ASEAN Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Ambulatory Surgical Center, 2017-2032 (USD Million)
  • TABLE 195. ASEAN Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Hospital, 2017-2032 (USD Million)
  • TABLE 196. ASEAN Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 197. ASEAN Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 198. ASEAN Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Offline Channel, 2017-2032 (USD Million)
  • TABLE 199. GCC Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 200. GCC Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 201. GCC Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Balloon Expandable, 2017-2032 (USD Million)
  • TABLE 202. GCC Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Self Expanding, 2017-2032 (USD Million)
  • TABLE 203. GCC Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 204. GCC Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Myocardial Infarction, 2017-2032 (USD Million)
  • TABLE 205. GCC Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Stable Angina, 2017-2032 (USD Million)
  • TABLE 206. GCC Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 207. GCC Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Ambulatory Surgical Center, 2017-2032 (USD Million)
  • TABLE 208. GCC Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Hospital, 2017-2032 (USD Million)
  • TABLE 209. GCC Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 210. GCC Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 211. GCC Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Offline Channel, 2017-2032 (USD Million)
  • TABLE 212. European Union Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 213. European Union Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 214. European Union Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Balloon Expandable, 2017-2032 (USD Million)
  • TABLE 215. European Union Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Self Expanding, 2017-2032 (USD Million)
  • TABLE 216. European Union Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 217. European Union Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Myocardial Infarction, 2017-2032 (USD Million)
  • TABLE 218. European Union Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Stable Angina, 2017-2032 (USD Million)
  • TABLE 219. European Union Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 220. European Union Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Ambulatory Surgical Center, 2017-2032 (USD Million)
  • TABLE 221. European Union Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Hospital, 2017-2032 (USD Million)
  • TABLE 222. European Union Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 223. European Union Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 224. European Union Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Offline Channel, 2017-2032 (USD Million)
  • TABLE 225. BRICS Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 226. BRICS Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 227. BRICS Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Balloon Expandable, 2017-2032 (USD Million)
  • TABLE 228. BRICS Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Self Expanding, 2017-2032 (USD Million)
  • TABLE 229. BRICS Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 230. BRICS Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Myocardial Infarction, 2017-2032 (USD Million)
  • TABLE 231. BRICS Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Stable Angina, 2017-2032 (USD Million)
  • TABLE 232. BRICS Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 233. BRICS Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Ambulatory Surgical Center, 2017-2032 (USD Million)
  • TABLE 234. BRICS Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Hospital, 2017-2032 (USD Million)
  • TABLE 235. BRICS Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 236. BRICS Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 237. BRICS Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Offline Channel, 2017-2032 (USD Million)
  • TABLE 238. G7 Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 239. G7 Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 240. G7 Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Balloon Expandable, 2017-2032 (USD Million)
  • TABLE 241. G7 Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Self Expanding, 2017-2032 (USD Million)
  • TABLE 242. G7 Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 243. G7 Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Myocardial Infarction, 2017-2032 (USD Million)
  • TABLE 244. G7 Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Stable Angina, 2017-2032 (USD Million)
  • TABLE 245. G7 Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 246. G7 Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Ambulatory Surgical Center, 2017-2032 (USD Million)
  • TABLE 247. G7 Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Hospital, 2017-2032 (USD Million)
  • TABLE 248. G7 Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 249. G7 Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 250. G7 Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Offline Channel, 2017-2032 (USD Million)
  • TABLE 251. NATO Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 252. NATO Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 253. NATO Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Balloon Expandable, 2017-2032 (USD Million)
  • TABLE 254. NATO Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Self Expanding, 2017-2032 (USD Million)
  • TABLE 255. NATO Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 256. NATO Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Myocardial Infarction, 2017-2032 (USD Million)
  • TABLE 257. NATO Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Stable Angina, 2017-2032 (USD Million)
  • TABLE 258. NATO Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 259. NATO Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Ambulatory Surgical Center, 2017-2032 (USD Million)
  • TABLE 260. NATO Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Hospital, 2017-2032 (USD Million)
  • TABLE 261. NATO Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 262. NATO Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 263. NATO Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Offline Channel, 2017-2032 (USD Million)
  • TABLE 264. Global Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 265. United States Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 266. United States Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 267. United States Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Balloon Expandable, 2017-2032 (USD Million)
  • TABLE 268. United States Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Self Expanding, 2017-2032 (USD Million)
  • TABLE 269. United States Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 270. United States Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Myocardial Infarction, 2017-2032 (USD Million)
  • TABLE 271. United States Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Stable Angina, 2017-2032 (USD Million)
  • TABLE 272. United States Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 273. United States Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Ambulatory Surgical Center, 2017-2032 (USD Million)
  • TABLE 274. United States Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Hospital, 2017-2032 (USD Million)
  • TABLE 275. United States Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 276. United States Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 277. United States Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Offline Channel, 2017-2032 (USD Million)
  • TABLE 278. Canada Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 279. Canada Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 280. Canada Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Balloon Expandable, 2017-2032 (USD Million)
  • TABLE 281. Canada Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Self Expanding, 2017-2032 (USD Million)
  • TABLE 282. Canada Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 283. Canada Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Myocardial Infarction, 2017-2032 (USD Million)
  • TABLE 284. Canada Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Stable Angina, 2017-2032 (USD Million)
  • TABLE 285. Canada Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 286. Canada Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Ambulatory Surgical Center, 2017-2032 (USD Million)
  • TABLE 287. Canada Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Hospital, 2017-2032 (USD Million)
  • TABLE 288. Canada Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 289. Canada Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
  • TABLE 290. Canada Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, by Offline Channel, 2017-2032 (USD Million)
  • TABLE 291. Mexico Bioabsorbable Sirolimus-eluting Coronary Stent System Market Size, 2017-2032 (